...oltage Clamp, as a Current Clamp or as a Conductan...pplications. Performance in any one mode is as goo...s amazing instrument is made possible by very rece...Processing (DSP) integrated circuit chips. Until v...
... a shutter (controlled via a TTL signal or switch ...gen Light Source combines the continuous spectrum ... a single optical path. The combined-spectrum ligh...15-200 nm. In addition, deep-UV versions of the li...
... expressed in g per ml and is determined from seri... of a 1 mg per ml solution. This activity is the...on of human blood group A erythrocytes after 1 hou... purified by a modification of the method of Hamme...
Agilent MSD Security ChemStation for GC and GC/MS from Agilent Technologies
Biology Products:(Date:12/2/2009)... CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolyti...SX:ONC; NASDAQ: ONCY ) announced today that in con...g, the underwriters have exercised in full their o...37,500 units. Each unit is comprised of one common... and was sold at a price of US$3.00 per unit. Each...
(Date:12/2/2009)...SINGAPORE, Dec. 2 S*BIO Pte Ltd to... JAK2 inhibitor, SB1518, at The American Society o... New Orleans. ,, Data will be presented on the ...trial of SB1518 detailing its safety, tolerability...le in dose levels ranging from 100 to 600 mg. Thes...
(Date:12/2/2009)... The Scientist, a leading scientific magazi...’ Evolve “Intelligent” EMCCD cam...p 10 Innovations of 2009. , ... EMCCD camera from Photometrics ®, a designe...CD cameras for the life sciences, was ranked fourt...
(Date:12/1/2009)...NEW YORK, Dec. 1 Reportlinker.com ...ilable in its catalogue: ,, Industrial Enzymes...tlinker.com/p0164431/Industrial-Enzymes---A-Global...et is an oligopoly with few strong players and a h...ivities. Keen competition and commoditization char...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10